David C. Montefiori

86.4k total citations · 7 hit papers
616 papers, 33.7k citations indexed

About

David C. Montefiori is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, David C. Montefiori has authored 616 papers receiving a total of 33.7k indexed citations (citations by other indexed papers that have themselves been cited), including 548 papers in Virology, 346 papers in Immunology and 201 papers in Infectious Diseases. Recurrent topics in David C. Montefiori's work include HIV Research and Treatment (545 papers), Immune Cell Function and Interaction (240 papers) and HIV/AIDS drug development and treatment (116 papers). David C. Montefiori is often cited by papers focused on HIV Research and Treatment (545 papers), Immune Cell Function and Interaction (240 papers) and HIV/AIDS drug development and treatment (116 papers). David C. Montefiori collaborates with scholars based in United States, United Kingdom and Netherlands. David C. Montefiori's co-authors include John R. Mascola, Norman L. Letvin, Barton F. Haynes, Celia C. LaBranche, Miroslawa Bilska, Michael S. Seaman, Jörn E. Schmitz, William M. Mitchell, Sampa Santra and William E. Robinson and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

David C. Montefiori

603 papers receiving 33.1k citations

Hit Papers

Control of Viremia in Simian Immunodeficiency Virus Infec... 1995 2026 2005 2015 1999 2005 1995 2002 2009 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes
    1999 1.8k citations Jörn E. Schmitz, Marcelo J. Kuroda et al. Science profile →
  2. Human Immunodeficiency Virus Type 1envClones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
    2005 845 citations John R. Mascola, Leonidas Stamatatos et al. Journal of Virology profile →
  3. Studies in Subjects with Long-Term Nonprogressive Human Immunodeficiency Virus Infection
    1995 562 citations David C. Montefiori et al. profile →
  4. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
    2002 544 citations Dan H. Barouch, Marcelo J. Kuroda et al. profile →
  5. Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
    2009 446 citations Michael S. Seaman, Natalie Hawkins et al. Journal of Virology profile →
  6. A Bivalent Omicron-Containing Booster Vaccine against Covid-19
    2022 346 citations David C. Montefiori et al. profile →
  7. SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
    2021 222 citations David C. Montefiori et al. profile →

Peers

David C. Montefiori
John R. Mascola United States
George M. Shaw United States
Jeffrey D. Lifson United States
John P. Moore United States
Richard A. Koup United States
Bette Korber United States
Gary J. Nabel United States
Joseph Sodroski United States
Norman L. Letvin United States
Jaap Goudsmit Netherlands
John R. Mascola United States
David C. Montefiori
Citations per year, relative to David C. Montefiori David C. Montefiori (= 1×) peers John R. Mascola

Countries citing papers authored by David C. Montefiori

Since Specialization
Citations

This map shows the geographic impact of David C. Montefiori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Montefiori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Montefiori more than expected).

Fields of papers citing papers by David C. Montefiori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Montefiori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Montefiori. The network helps show where David C. Montefiori may publish in the future.

Co-authorship network of co-authors of David C. Montefiori

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Montefiori. A scholar is included among the top collaborators of David C. Montefiori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Montefiori. David C. Montefiori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gray, Matthew D., Junli Feng, Connor Weidle, et al.. (2022). Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain. Science Advances. 8(18). eabm3948–eabm3948. 2 indexed citations
2.
Montefiori, David C., et al.. (2021). The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat. Proceedings of the National Academy of Sciences. 118(3). 15 indexed citations
3.
Fong, Youyi, Maria Dennis, Joshua Eudailey, et al.. (2021). Frequent Development of Broadly Neutralizing Antibodies in Early Life in a Large Cohort of Children With Human Immunodeficiency Virus. The Journal of Infectious Diseases. 225(10). 1731–1740. 6 indexed citations
4.
Gautam, Rajeev, Yoshiaki Nishimura, W. Robert Lee, et al.. (2012). Pathogenicity and Mucosal Transmissibility of the R5-Tropic Simian/Human Immunodeficiency Virus SHIV AD8 in Rhesus Macaques: Implications for Use in Vaccine Studies. Journal of Virology. 86(16). 8516–8526. 35 indexed citations
5.
Sellhorn, George, Zane Kraft, Zachary Caldwell, et al.. (2011). Engineering, Expression, Purification, and Characterization of Stable Clade A/B Recombinant Soluble Heterotrimeric gp140 Proteins. Journal of Virology. 86(1). 128–142. 26 indexed citations
6.
Melchers, Mark, Ilja Bontjer, Tommy Tong, et al.. (2011). Targeting HIV-1 Envelope Glycoprotein Trimers to B Cells by Using APRIL Improves Antibody Responses. Journal of Virology. 86(5). 2488–2500. 39 indexed citations
7.
Mörner, Andreas, Marianne Jansson, Evelien M. Bunnik, et al.. (2011). Immunization with Recombinant HLA Classes I and II, HIV-1 gp140, and SIV p27 Elicits Protection against Heterologous SHIV Infection in Rhesus Macaques. Journal of Virology. 85(13). 6442–6452. 14 indexed citations
8.
Robinson, James E., Debra Elliott, David C. Montefiori, et al.. (2010). Quaternary Epitope Specificities of Anti-HIV-1 Neutralizing Antibodies Generated in Rhesus Macaques Infected by the Simian/Human Immunodeficiency Virus SHIV SF162P4. Journal of Virology. 84(7). 3443–3453. 37 indexed citations
9.
O’Keefe, Barry R., Fakhrieh Vojdani, Viviana Buffa, et al.. (2009). Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. Proceedings of the National Academy of Sciences. 106(15). 6099–6104. 208 indexed citations
10.
Barouch, Dan H., Jinyan Liu, Diana M. Lynch, et al.. (2009). Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine against Simian Immunodeficiency Virus Challenge in Rhesus Monkeys. Journal of Virology. 83(18). 9584–9590. 26 indexed citations
11.
Veazey, Ronald S., Susanne H.C. Baumeister, Melisa D. Rett, et al.. (2008). Increased Loss of CCR5 + CD45RA − CD4 + T Cells in CD8 + Lymphocyte-Depleted Simian Immunodeficiency Virus-Infected Rhesus Monkeys. Journal of Virology. 82(11). 5618–5630. 30 indexed citations
12.
Binley, James Μ., Emma T. Crooks, Michael S. Seaman, et al.. (2008). Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C. Journal of Virology. 82(23). 11651–11668. 278 indexed citations
13.
14.
Siddappa, Nagadenahalli B., Ruijiang Song, Victor G. Kramer, et al.. (2008). Neutralization-Sensitive R5-Tropic Simian-Human Immunodeficiency Virus SHIV-2873Nip, Which Carries env Isolated from an Infant with a Recent HIV Clade C Infection. Journal of Virology. 83(3). 1422–1432. 32 indexed citations
15.
Miller, Christopher J., Meritxell Genescà, Kristina Abel, et al.. (2007). Antiviral Antibodies Are Necessary for Control of Simian Immunodeficiency Virus Replication. Journal of Virology. 81(10). 5024–5035. 64 indexed citations
16.
Alam, S. Munir, Richard M. Scearce, Robert Parks, et al.. (2007). Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection. Journal of Virology. 82(1). 115–125. 85 indexed citations
17.
Santra, Sampa, Yue Sun, Jenny G. Parvani, et al.. (2007). Heterologous Prime/Boost Immunization of Rhesus Monkeys by Using Diverse Poxvirus Vectors. Journal of Virology. 81(16). 8563–8570. 36 indexed citations
18.
Letvin, Norman L., John R. Mascola, Yue Sun, et al.. (2006). Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys. Science. 312(5779). 1530–1533. 287 indexed citations
19.
Garber, David A., Guido Silvestri, Ashley P. Barry, et al.. (2004). Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication. Journal of Clinical Investigation. 113(6). 836–845. 42 indexed citations
20.
Garber, David A., Guido Silvestri, Ashley P. Barry, et al.. (2004). Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication. Journal of Clinical Investigation. 113(6). 836–845. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John R. Mascola Breakdown of academic impact, for papers by George M. Shaw Breakdown of academic impact, for papers by Jeffrey D. Lifson Breakdown of academic impact, for papers by John P. Moore Breakdown of academic impact, for papers by Richard A. Koup Breakdown of academic impact, for papers by Bette Korber Breakdown of academic impact, for papers by Gary J. Nabel Breakdown of academic impact, for papers by Joseph Sodroski Breakdown of academic impact, for papers by Norman L. Letvin Breakdown of academic impact, for papers by Jaap Goudsmit
Rankless by CCL
2026